In patients with conditions characterized by involuntary bladder contractions, cystometric
20
Oxybutynin extended-release tablets is also used to treat children 6 years of age and older who have an overactive bladder caused by a certain nerve disorder (eg, spina
The volume of distribution was estimated to be 193 L after intravenous administration of 5 mg oxybutynin hydrochloride
Although efficacious for treating OAB symptoms, the side effects and suboptimal dosing regimen decrease its utility
The recommended starting dose of DITROPAN XL® is 5 or 10 mg once daily at approximately the same time each day
Extended-release tablets: 5 mg once daily for children ≥6 years of age
Drugs List
1
Oxybutynin Chloride Oral Solution, USP 5 mg/5 mL (Light Red color liquid with cherry flavor) is supplied in bottles of 16 fluid ounces (473 mL) (NDC 62135-520-47)
o Hypersensitivity to the active substance or to any of the excipients listed in section 6
5
The absolute bioavailability of oxybutynin is reported to be about 6% (range 1
The phase IV clinical study analyzes what interactions people who take Oxybutynin chloride and Tylenol have
Absorption
Oxybutynin chloride should be administered with caution to patients with gastrointestinal obstructive disorders because of the risk of gastric retention (see CONTRAINDICATIONS)
Oxybutynin is an antispasmodic, anticholinergic agent
Helps with bladder control in people with an overactive bladder, urinary incontinence, or urinary leakage